CHRNA7 and Alzheimer disease: Additionally, it was shown that LPS administration in the experimental model reduced the levels of the α7 nicotinic acetylcholine receptor in the brain, indicating an additional way that LPS causes neuroinflammation and cognitive impairment in AD models (Figure 3) (105).